cover
Contact Name
Dr. Erina Yatmasari, dr.,M.Kes.
Contact Email
erina.yatmasari@gmail.com
Phone
-
Journal Mail Official
biomedicina@hangtuah.ac.id
Editorial Address
-
Location
Kota surabaya,
Jawa timur
INDONESIA
Oceana Biomedicina Journal
ISSN : -     EISSN : 26140519     DOI : -
Core Subject : Health, Science,
Hyperbaric medicine, marine medicine other than hyperbaric, on ships, boats and harbor health, maritime and coastal health, medicolegal aspects and medicolegal related to ships, ports and districts / maritime / coastal communities and fishermen, epidemiological aspects of diseases, disabilities and disorders both major and minor occurs of ships and boat workers, ports and maritime zones, coastal areas, fishermen communities and their families, including pharmacological and non-pharmacological prevention and treatment management policies.
Arjuna Subject : -
Articles 5 Documents
Search results for , issue " Vol 1, No 2 (2018): Oceana Biomedicina Journal" : 5 Documents clear
Current Therapy of Rheumatoid Arthritis (Recent Therapeutics Policies of Rheumatoid Arthritis part 2) Andisari, Hendrata Erry
Oceana Biomedicina Journal Vol 1, No 2 (2018): Oceana Biomedicina Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (563.148 KB) | DOI: 10.30649/obj.v1i2.14

Abstract

Therapy in RA has undergone many advances today and in line with knowledge of the pathogenesis of RA, the current therapeutic goal is to alter the journey and control the activity of RA disease. Several groups of drugs have been used in RA therapy including non-steroidal anti-inflammatory drugs (NSAIDs), conventional disease-modifying antirheumatic drugs (DMARDs) as well as biological agents (bDMARD), glucocorticoids and anti-pain medicines. In recent years, the development of biological agents that have specific targets for inflammatory mediators such as interleukin (IL) -1, IL-6 and Tumor Necrosis Factor (TNF) suggests a potent therapeutic effect on RA. In this article will be presented the latest biological agents as the latest therapy on RA. Keywords : conventional DMARDs, biological agents
Analisis Biaya dan Nilai Utilitas Pasien Hemodialisa yang Diberikan Terapi Sevelamer Karbonat Safnurbaiti, Dwi Putri; Andayani, Tri Murti; Irijanto, Fredie
Oceana Biomedicina Journal Vol 1, No 2 (2018): Oceana Biomedicina Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (614.894 KB) | DOI: 10.30649/obj.v1i2.12

Abstract

Sevelamer karbonat merupakan alternatif lain sebagai terapi pengikat fosfat yang diberikan kepada pasien hemodialisa selain CaCO3. Sevelamer karbonat dapat menurunkan kadar fosfat, mengurangi kejadian kalsifikasi vaskular dan mortalitas yang secara langsung berdampak pada perbaikan kualitas hidup pasien hemodialisa, namun harga sevelamer karbonat lebih mahal dibandingkan dengan CaCO3. Penelitian ini bertujuan untuk mengetahui gambaran biaya yang diperlukan untuk terapi sevelamer karbonat dan nilai utilitas pasien hemodialisa yang menggunakan terapi sevelamer karbonat di RS UGM Yogyakarta.Penelitian dilakukan secara prospektif selama 8 minggu di RS UGM Yogyakarta pada bulan Oktober-November 2016. Desain penelitian adalah quasi eksperimental dengan “pretest posttest design with control group”. Kelompok eksperimental adalah sevelamer karbonat dan kontrol adalah CaCO3. Pengukuran health related quality of life (HRQOL) pasien hemodialisa salah satunya dengan mengukur utilitas pasien hemodialisa dengan kuesioner EQ-5D-5L pada awal (pre) dan akhir (post) penelitian. Analisis biaya dilihat berdasarkan perspektif rumah sakit dengan menghitung totaldirect medical cost.Jumlah total responden dalam penelitian ini adalah 37 pasien yang terdiri atas 16 pasien kelompok eksperimental dan 21 pasien kelompok kontrol. Rata-rata biaya yang diperlukan pasien hemodialisa dengan sevelamer karbonat untuk menangani kondisi gangguan mineral dan tulang adalah sebesar Rp2.999.188,75±167.920,75 per pasien selama 8 minggu terapi. Nilai utilitas dan skor EQ-5D VAS baseline pasien hemodialisa yang diberikan sevelamer karbonat adalah masing-masing 0,91±0,13 dan 75,93±9,34, dan di akhir penelitian (posttes) terdapat perubahan nilai utilitas dan skor EQ-5D VAS sebesar 0,93±0,08 dan 77,44±11,12. Hasil uji statistik menunjukkan bahwa perubahan nilai utilitas dan skor EQ-5D VAS pasien hemodialisa yang diberikan sevelamer karbonat antara awal (pre) dan akhir penelitian (posttes) adalah menunjukkan tidak berbeda bermakna (p>0,05).Kata Kunci : analisis biaya,EQ-5D-5L, nilai utilitas, hemodialisa,sevelamer karbonat
Empirical Antibiotic Therapy Assessment of Patients diagnosed with Sepsis in Intermediate Care Ward of Internal Medicine Department of Dr. Soetomo General Hospital according to Gyssens Method Adiwinoto, Ronald Pratama; Sustini, Florentina; Hardiono, Hardiono; Widodo, Agung Dwi Wahyu; Hidajat, Boerhan; Hadi, Usman
Oceana Biomedicina Journal Vol 1, No 2 (2018): Oceana Biomedicina Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (546.601 KB) | DOI: 10.30649/obj.v1i2.17

Abstract

Rational empirical antimicrobial therapy is an important component of sepsis patient management. This study aimed to assess the rationality of empirical antimicrobial therapy in patients diagnosed with sepsis admitted in intermediate care ward of internal medicine department (RPI) of Dr. Soetomo General Hospital from January 2016 to July 2017. Medical records of 91 patients diagnosed with sepsis were collected and studied retrospectively in period from July 2017 to November 2017. 91 (85.05%) medical records from 107 sepsis patients were evaluated. Cultures and antimicrobial sensitivity tests were carried out in 21 (23.07%) patients. 14 patients yielded positive culture results, 9 of which were MDRO positive with ESBL as resistant marker. Empirical antibiotic therapies for these patients were reviewed according to Gyssens method.73 (80.2%) of 91 patients were deemed receiving appropriate empirical antibiotic therapies. Ceftriaxone IV injection as monotherapy or combination therapy were the most common empirical antibiotic therapies (82 in 91 patients, 90.1%), despite local microbiologic flora and antibiogram show most pathogens were resistant to ceftriaxone. Mortality rate in this study was high, 92.3% (84 patients died) despite rational empirical antibiotic therapies were high. This study concluded that empirical antibiotic therapies in sepsis patients according to guidelines adopted in Soetomo General Hospital, albeit deemed rational, was no longer appropriate according to local antibiogram issued by microbiological department of Soetomo General Hospital. Keywords: Empirical Antibiotics Therapy, Gyssens criteria, Intermediate Care Ward, Sepsis, Septic Shock
Molecular Mechanism of Cholerae Toxin (ctx) in Causing Diarrhea Praja, Rian Kusuma Arinta; Rosalina, Reny
Oceana Biomedicina Journal Vol 1, No 2 (2018): Oceana Biomedicina Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (761.654 KB) | DOI: 10.30649/obj.v1i2.16

Abstract

Vibrio cholerae is one of the pathogenic bacteria transmitted through contaminated food, especially seafood and contaminated beverages. V. cholerae produces cholerae toxin (ctx) which is encoded by the ctx gene located within its chromosome. This toxin has been recognized as one of the toxins responsible for cholera outbreaks. The mechanism of ctx gene expression is induced by environmental signals such as pH, osmolarity, temperature, bile, amino acids, and CO2. These signals will be a positive transcriptional factor to the ToxR gene that regulates the biogenesis of cholerae toxin. After cholerae toxin has been successfully expressed, V. cholerae uses a type II secretion (T2S) pathway to deliver cholerae toxin to the extracellular environment. Cholerae toxin consists of A and B subunits. The B subunit plays a role in attaching to the receptor Manosialosyl Ganglioside (GM1 ganglioside) and the A subunit plays a role in catalyzing ADP-ribosylation of Gs (stimulatory) proteins and turning them into active condition. The Gs proteins will convert the inactive adenilate cyclase (AC) into active AC. The increase of AC activity will increase the cyclic adenosine 3'5'-monophosphate (cAMP) concentration along the cell membrane. The cAMP then causes the active secretion of sodium (Na+), chloride (Cl-), potassium (K+), bicarbonate (HCO3-), and water (H2O) out of the cell into the intestinal lumen, resulting in large fluid losses and electrolyte imbalances. Keywords: Vibrio cholerae, cholerae toxin (ctx), ToxR gene, type II secretion (T2S), GM1 ganglioside, adenilate cyclase.
Cervix Carcinoma: Pathological Aspect Nefertiti, Eva Pravitasari
Oceana Biomedicina Journal Vol 1, No 2 (2018): Oceana Biomedicina Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (484.693 KB) | DOI: 10.30649/obj.v1i2.15

Abstract

Cervix carcinoma is a malignancy at squamocollumnar junction, in the border between ecto and endo cervix. Lesion at this site is frequently correlated with chronic inflammatory of the cervix, displacia, and in situ carcinoma. InIndonesia, cervix carcinoma is the most common malignancy in women. At Obstetry and Gynecology Department of RSCM during 1986-1990 period, 2360 gynocology carcinoma were found, and 1821 (77,2%) cases of them were cervix carcinoma. The diagnosis was made based on cytology, colposcopy, biopsy, endocervix curettage and conitation. Papanicolaou test is a useful in detecting early stage of cervix carcinoma up to 90% accuration. The speciment for paps smear is secrets of the vagina, cervix, endocervix, endometrium, and posterior fornix.key words : cervix carcinoma, cytology, papsmear

Page 1 of 1 | Total Record : 5